Indications
Treosulfan in combination with fludarabine is indicated as part of conditioning treatment prior to allogeneic haematopoietic stem cell transplantation (alloHSCT) in adult patients and in paediatric patients older than one month with malignant and non-malignant diseases.
Composition
- Active substance
- treosulfan
Official product information
The European public assessment report holds the summary of product characteristics and the package leaflet in every EU language.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Medicine
- Trecondi
- Active substance
- treosulfan
- ATC code
- L01AB02
- Therapeutic area
- Hematopoietic Stem Cell Transplantation
- Marketing authorisation holder
- medac Gesellschaft für klinische Spezialpräparate mbH